Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412848
Status:
COMPLETED
Last Update Posted:
2024-07-08
First Post:
2024-04-23
Brief Title:
JAVEMACS Japan AVElumab Maintenance And Continuous Treatment Study
Sponsor:
Organization:
Merck Healthcare KGaA Darmstadt Germany an affiliate of Merck KGaA Darmstadt Germany